Nuvation Bio (NUVB) has quietly turned into one of the market’s stronger biotech movers, with the stock up about 78% over the past month and more than tripling year to date. See our latest analysis ...

Neochem Bio Solutions share price made a strong debut on the Indian stock market on Tuesday, December 9. Neochem Bio Solutions shares are listed at a premium of 10.2% over the IPO price. Neochem Bio ...

Once again, Netflix’s “The Price of Confession” swept the top spots on this week’s rankings of the most buzzworthy dramas and actors! For the second week in a row, “The Price of Confession” remained ...

Netflix’s “The Price of Confession” dominated this week’s rankings of the most buzzworthy dramas and actors! This week, “The Price of Confession” debuted at No. 1 on Good Data Corporation’s weekly ...

Actor Jeon Do-yeon explained why she decided to appear in The Price of Confession despite the actor replacement issue. On the afternoon of the 12th at a cafe in Samcheong-dong, Jongno-gu, Seoul, a ...

H.C. Wainwright raised the firm’s price target on Nuvation Bio (NUVB) to $18 from $10 and keeps a Buy rating on the shares. The firm cites its revised Ibtrozi revenue forecasts for the target increase ...

Wedbush lowered the firm’s price target on Generation Bio (GBIO) to $5.50 from $7 and keeps a Neutral rating on the shares. Xoma (XOMA) will acquire Generation Bio for $4.2913/share plus a ...

After his son was repeatedly attacked, Rick Kuehner reached out to his suburban school, to the police and to other parents. The violence only got worse. Tristan Kuehner with his father, Rick, in ...

The latest price target for Belite Bio (NASDAQ:BLTE) was reported by Mizuho on December 2, 2025. The analyst firm set a price target for $194.00 expecting BLTE to rise to within 12 months (a possible ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 clinical ...